Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Hallucinogens
Hallucinogens are mood-altering drugs that cause the user to experience hallucinations, dissociation from reality, or delirium. Hallucinogens such as psilocybin (mushrooms) and mescaline (peyote) are naturally occurring, while LSD, MDMA, PCP, and ketamine are synthetic substances. Abuse of hallucinogens can cause memory impairment, anxiety attacks, flashbacks, nausea, and vomiting. High doses of hallucinogens like PCP can cause convulsions, coma, and death. Hallucinogens provides important information on the nature and chemistry of these drugs, their effects, how they are abused, and related social and legal issues. Drugs are part of everyday life. They can be found on the street, in school,...
Opium
Describes what opium is, how it is cultivated and how it is used and abused.
Body Enhancement Products
Examines the history of body enhancement products, the different types and their effects on the body, nutritional supplements, drug testing, teenage trends and attitudes, ethics, the law and more.
Managed Care Pharmacy Practice
Managed Care Pharmacy Practice, Second Edition offers information critical to the development and operation of a managed care pharmacy program. The text also covers the changes that have taken place within the delivery of pharmacy services, as well as the evolving role of pharmacists.
Opium
Discusses the history and effects of using opium, the dangers of addiction, and treatments.
Biopharmaceutical Supply Chains
A comprehensive exploration of the massive changes in the biopharmaceutical supply chain that have occurred during the past 10 years, and predicted future trends, Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead documents the specific impacts of these changes for key players in the supply chain. Based
Preventing Medication Errors
In 1996 the Institute of Medicine launched the Quality Chasm Series, a series of reports focused on assessing and improving the nation's quality of health care. Preventing Medication Errors is the newest volume in the series. Responding to the key messages in earlier volumes of the seriesâ€"To Err Is Human (2000), Crossing the Quality Chasm (2001), and Patient Safety (2004)â€"this book sets forth an agenda for improving the safety of medication use. It begins by providing an overview of the system for drug development, regulation, distribution, and use. Preventing Medication Errors also examines the peer-reviewed literature on the incidence and the cost of medication errors and the eff...
The Future of Drug Safety
In the wake of publicity and congressional attention to drug safety issues, the Food and Drug Administration (FDA) requested the Institute of Medicine assess the drug safety system. The committee reported that a lack of clear regulatory authority, chronic underfunding, organizational problems, and a scarcity of post-approval data about drugs' risks and benefits have hampered the FDA's ability to evaluate and address the safety of prescription drugs after they have reached the market. Noting that resources and therefore efforts to monitor medications' riskâ€"benefit profiles taper off after approval, The Future of Drug Safety offers a broad set of recommendations to ensure that consideration of safety extends from before product approval through the entire time the product is marketed and used.
